Regulatory agilities and further accelerating patient access to safe and effective medicines and vaccines
- Special Session: Regulatory agilities in the time of COVID-19 and beyond- perspectives from Singapore
- Opening & Welcome to the 11th ARC
- Regulatory Agilities & PQ KMS: What does it potentially mean for Asia?
- Fireside Chat: Why are innovative and agile regulatory systems important for patients, and how are patients engaging in regulatory activities?
- IFPMA Regulatory Agilities Project & Recommendations
- Perspectives on/Use of Regulatory Agilities in Asia
- Panel Session with Audience Q&A